The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.

Peroxisome Proliferator-Activated Receptors (PPARs) are a family of nuclear receptors that play essential roles in modulating cell differentiation, inflammation, and metabolism. Three subtypes of PPARs are known: PPAR-alpha (PPARα), PPAR-gamma (PPARγ), and PPAR-beta/delta (PPARβ/δ). PPARα activation reduces lipid levels and regulates energy homeostasis, activation of PPARγ results in regulation of adipogenesis, and PPARβ/δ activation increases fatty acid metabolism and lipolysis. PPARs are linked to various diseases, including but not limited to diabetes, non-alcoholic fatty liver disease, glaucoma and atherosclerosis. In the past decade, numerous studies have assessed the functional properties of PPARs in the eye and key PPAR mechanisms have been discovered, particularly regarding the retina and cornea. PPARγ and PPARα are well established in their functions in ocular homeostasis regarding neuroprotection, neovascularization, and inflammation, whereas PPARβ/δ isoform function remains understudied. Naturally, studies on PPAR agonists and antagonists, associated with ocular pathology, have also gained traction with the development of PPAR synthetic ligands. Studies on PPARs has significantly influenced novel therapeutics for diabetic eye disease, ocular neuropathy, dry eye, and age-related macular degeneration (AMD). In this review, therapeutic potentials and implications will be highlighted, as well as reported adverse effects. Further investigations are necessary before any of the PPARs ligands can be utilized, in the clinics, to treat eye diseases. Future research on the prominent role of PPARs will help unravel the complex mechanisms involved in order to prevent and treat ocular diseases.

• Publication year

  2021

• Venue

  Experimental Eye Research

• Publication date

  2021-05-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.exer.2021.108617PMID 34010603PMCID PMC8594540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Keratocytes promote corneal neovascularization through VEGFr3 induced by PPARα-inhibition.

  2020cited by this paper
• Descemet's membrane development, structure, function and regeneration.

  2020cited by this paper
• PPAR Beta/Delta and the Hallmarks of Cancer

  2020cited by this paper
• Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus

  2020cited by this paper
• Corneal epithelial biology: Lessons stemming from old to new.

  2020cited by this paper
• Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes

  2020cited by this paper
• PPAR-α Agonist Fenofibrate Suppressed the Formation of Ocular Surface Squamous Metaplasia Induced by Topical Benzalkonium Chloride

  2020cited by this paper
• Anatomy, Head and Neck, Eye Lacrimal Gland

  2020cited by this paper
• Bowman's layer in the cornea- structure and function and regeneration.

  2020cited by this paper
• Diabetic Keratopathy: Insights and Challenges.

  2020cited by this paper
• Alzheimer’s Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α

  2020cited by this paper
• Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization

  2020cited by this paper
• A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism

  2019cited by this paper
• Neuroprotective effects of PPARα in retinopathy of type 1 diabetes

  2019cited by this paper
• New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy

  2019cited by this paper
• An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway

  2019cited by this paper
• Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice

  2019cited by this paper
• Anatomy of cornea and ocular surface

  2018cited by this paper
• Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future

  2018cited by this paper
• PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth.

  2018cited by this paper
• Reactive Oxygen Species-Mediated Damage of Retinal Neurons: Drug Development Targets for Therapies of Chronic Neurodegeneration of the Retina

  2018cited by this paper
• Corneal Innervation and Sensation: The Eye and Beyond

  2018cited by this paper
• Peroxisome Proliferated Activated Receptors (PPARs): Opportunities and Challenges for Ocular Therapy.

  2018cited by this paper
• Sleep Deprivation Induces Dry Eye Through Inhibition of PPARα Expression in Corneal Epithelium.

  2018cited by this paper
• The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor

  2018cited by this paper
• Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism

  2018cited by this paper
• Inhibition of Human Corneal Myofibroblast Formation

  2018cited by this paper
• PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders

  2018cited by this paper
• Probing the role of PPARγ in the regulation of late-onset Alzheimer’s disease-associated genes

  2018cited by this paper
• Physiology and Pathophysiology of PPARs in the Eye

  2018cited by this paper
• Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia

  2017cited by this paper
• Hematopoietic stem/progenitor involvement in retinal microvascular repair during diabetes: Implications for bone marrow rejuvenation

  2017cited by this paper
• Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study.

  2017cited by this paper
• Do photoreceptor cells cause the development of retinal vascular disease?

  2017cited by this paper
• Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα

  2017cited by this paper
• PPARβ Is Essential for Maintaining Normal Levels of PGC-1α and Mitochondria and for the Increase in Muscle Mitochondria Induced by Exercise.

  2017cited by this paper
• PPARα is essential for retinal lipid metabolism and neuronal survival

  2017cited by this paper
• Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation

  2017cited by this paper
• Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ

  2017cited by this paper
• PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions

  2016cited by this paper
• Vascular and Central Activation of Peroxisome Proliferator–Activated Receptor-β Attenuates Angiotensin II–Induced Hypertension: Role of RGS-5

  2016cited by this paper
• Loss of PPARγ in endothelial cells leads to impaired angiogenesis

  2016cited by this paper
• Transcriptional architecture of the mammalian circadian clock

  2016cited by this paper
• Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis

  2016cited by this paper
• PPAR Gamma and Angiogenesis: Endothelial Cells Perspective

  2016cited by this paper
• The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review)

  2016cited by this paper
• Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

  2016cited by this paper
• PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration

  2016cited by this paper
• Why rods and cones?

  2016cited by this paper
• Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy.

  2015cited by this paper
• Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function

  2015cited by this paper
• Low-glucose enhances keratocyte-characteristic phenotype from corneal stromal cells in serum-free conditions

  2015cited by this paper
• PPARα Signaling in the Hippocampus: Crosstalk Between Fat and Memory

  2015cited by this paper
• Therapeutic Effects of PPARα on Neuronal Death and Microvascular Impairment

  2015cited by this paper
• Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.

  2015cited by this paper
• PPARγ and the Innate Immune System Mediate the Resolution of Inflammation

  2015cited by this paper
• Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms

  2015cited by this paper
• Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases

  2015cited by this paper
• RNA-seq identifies a role for the PPARβ/δ inverse agonist GSK0660 in the regulation of TNFα-induced cytokine signaling in retinal endothelial cells

  2015cited by this paper
• Inhibition of Oxygen-Induced Ischemic Retinal Neovascularization with Adenoviral 15-Lipoxygenase-1 Gene Transfer via Up-Regulation of PPAR-γ and Down-Regulation of VEGFR-2 Expression

  2014cited by this paper
• PPARs Integrate the Mammalian Clock and Energy Metabolism

  2014cited by this paper
• Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.

  2014cited by this paper
• Protective and antioxidant effects of PPARα in the ischemic retina.

  2014cited by this paper
• Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions.

  2014cited by this paper
• Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.

  2014cited by this paper
• PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway.

  2014cited by this paper
• Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine.

  2014cited by this paper
• Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor α and Suppressor of Cytokine Signaling 3*

  2014cited by this paper
• A role for the ciliary marginal zone in the melanopsin-dependent intrinsic pupillary light reflex.

  2014cited by this paper
• Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.

  2014cited by this paper
• Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.

  2014cited by this paper
• The Trabecular Meshwork: A Basic Review of Form and Function.

  2014cited by this paper
• Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases

  2014cited by this paper
• The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPARγ in Retinal Neuroprotection

  2013cited by this paper
• Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction

  2013cited by this paper
• PPARγ signaling and metabolism: the good, the bad and the future

  2013cited by this paper
• Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.

  2013cited by this paper
• An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model

  2013cited by this paper
• Anatomy of Ciliary Body, Ciliary Processes, Anterior Chamber Angle and Collector Vessels

  2013cited by this paper
• Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy[S]

  2013cited by this paper
• Role of Oxidative Stress in Parkinson's Disease

  2013cited by this paper
• Studying the effect of iris mechanics on the pupillary light reflex using brimonidine-induced anisocoria.

  2013cited by this paper
• Topical Rosiglitazone Is an Effective Anti-Scarring Agent in the Cornea

  2013cited by this paper
• Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension.

  2012cited by this paper
• Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders

  2012cited by this paper
• Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

  2012cited by this paper
• Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.

  2012cited by this paper
• Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

  2012cited by this paper
• Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models

  2012cited by this paper
• PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO

  2012cited by this paper
• Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-β are prevented by PPAR-γ agonists.

  2012cited by this paper
• An optic nerve crush injury murine model to study retinal ganglion cell survival.

  2011cited by this paper
• Ciliary blood flow and aqueous humor production.

  2011cited by this paper
• Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury

  2011cited by this paper
• PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation☆

  2011cited by this paper
• Supplementary file 1.

  2011cited by this paper
• Roles of Glucose in Photoreceptor Survival*

  2011cited by this paper
• The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2.

  2011cited by this paper
• Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension

  2011cited by this paper
• Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, induces dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels.

  2011cited by this paper

• Naringenin and quercetin nanoparticles as a dual strategy for topical management of diabetic retinopathy

  2026cites this paper
• PPARα-Dependent and Independent Mechanisms Are Complexly Involved in the Ameliorative Effect of a Dietary Supplement Containing Lactic Acid Bacteria in a Dry Eye Mouse Model.

  2026cites this paper
• Mini-Series Title: “Nuclear Receptors in Ocular Health and Disease: Therapeutic Horizons from Cornea to Retina”Title: “Nuclear Receptors: The Eye’s Hidden Gatekeepers of Inflammation, Lipids, and Repair” Part 1: Setting the Stage

  2026cites this paper
• DIFFERENCES BETWEEN AQUEOUS HUMOR AND SERUM CONCENTRATIONS OF BDNF AND PPARG GENETIC VARIANTS IN GLAUCOMA PATIENTS

  2025cites this paper
• Beyond lipids: fenofibrate in diabetic retinopathy and nephropathy.

  2025cites this paper
• Evaluating lipid-lowering drug targets for full-course diabetic retinopathy

  2025cites this paper
• The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice

  2025cites this paper
• Exploring novel roles of lipid droplets and lipid metabolism in regulating inflammation and blood–brain barrier function in neurological diseases

  2025cites this paper
• Fenofibrate and Diabetic Retinopathy

  2025cites this paper
• Fenofibrate inhibits activation of cGAS-STING pathway by alleviating mitochondrial damage to attenuate inflammatory response in diabetic dry eye.

  2025cites this paper
• Expression and Secretion of Intraocular Fatty Acid-Binding Protein 4 (ioFABP4) and 5 (ioFABP5) Are Regulated by Glucose Levels and Fatty Acids

  2025cites this paper
• Diabetic keratopathy and nuclear proteins (Review)

  2025influential citation
• Sustained release of a novel non-fibrate PPARα agonist from microparticles for neuroprotection in murine models of age-related macular degeneration.

  2025cites this paper
• Pemafibrate Induces a Low Level of PPARα Agonist-Stimulated mRNA Expression of ANGPTL4 in ARPE19 Cell

  2024cites this paper
• Retinal ischemic diseases and promising therapeutic molecular targets.

  2024cites this paper
• FABP4 Is an Indispensable Factor for Regulating Cellular Metabolic Functions of the Human Retinal Choroid

  2024cites this paper
• Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases

  2024influential citation
• Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features

  2024cites this paper
• Impact of natural compounds on peroxisome proliferator-activated receptor: Molecular effects and its importance as a novel therapeutic target for neurological disorders.

  2024cites this paper
• The role of PPAR in fungal keratitis

  2024cites this paper
• Effect of PPARγ on oxidative stress in diabetes-related dry eye.

  2023cites this paper
• The Effect of Turmeric and Mangosteen Peel Extract on PPARα Gene Expression in the Retina of HFD-Induced Rat Model

  2023cites this paper
• An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases

  2023cites this paper
• Dietary fish oil enriched in very-long-chain polyunsaturated fatty acid reduces cardiometabolic risk factors and improves retinal function

  2023cites this paper
• Novel Correlation between TGF-β1/-β3 and Hormone Receptors in the Human Corneal Stroma

  2023cites this paper
• Relationship between Using Fibrate and Open-Angle Glaucoma in Hyperlipidemic Patients: A Population-Based Cohort Study

  2022cites this paper
• Development of an Efficient New Route to PPARδ Agonist Fonadelpar: Formation of the C–C Bond by Claisen Condensation

  2022cites this paper
• Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury.

  2022cites this paper
• Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular disease.

  2022cites this paper
• Microbiota mitochondria disorders as hubs for early age-related macular degeneration

  2022cites this paper
• PPARα Modulation-Based Therapy in Central Nervous System Diseases

  2021cites this paper